Table 3.
Parameters | Control | STG | STG/Mn | STG/Co |
---|---|---|---|---|
ALT (U/L) | 12.51 ± 0.42 c (−−−) | 123.31 ± 6.69 a (++++) | 13.40 ± 0.82 bc (−−−) | 23.87 ± 3.14 b (−−−) |
AST (U/L) | 12.43 ± 0.37 c (−−−) | 164.26 ± 5.27 a (++++) | 11.27 ± 0.52 c (−−−) | 25.53 ± 3.20 b (−−−) |
LDH (U/L) | 84.05 ± 8.47 c (−−−) | 567.42 ± 47.00 a (++++) | 133.56 ± 11.91 c (−−−) | 220.02 ± 12.05 b (++−) |
Results are expressed as mean ± SE. Symbols are different alphabetically to indicate a significant comparison compared to the control group and other treated groups (p < 0.05) (Similar letters imply partial or complete nonsignificance). STG, Sitagliptin; ALT, Alanine aminotransferase; AST, Aspartate aminotransferase; LDH, Lactate dehydrogenase. Scoring of hepatic enzymes: (++++), moderate hepatic damage; (++−), slight hepatic damage; and (−−−), no hepatic damage.